NASDAQ:MACK
Merrimack Pharmaceuticals Stock News
$15.00
-0.0300 (-0.200%)
At Close: May 03, 2024
Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend
01:45pm, Tuesday, 03'rd Dec 2019
Merrimack Pharmaceuticals, Inc. (MACK) today announced that it received a $5 million milestone payment from Ipsen, triggered by Ipsen’s decision to progress the ongoing multi-part clinical trial eva
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
12:00am, Friday, 22'nd Nov 2019Western Standard, LLC Buys Extended Stay America Inc, Celgene Corp, Meta Financial Group Inc, ...
12:00am, Thursday, 14'th Nov 2019Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says
10:04am, Monday, 28'th Oct 2019
Attorney and proxy fight expert Kai Liekefett estimated that upwards of 10 percent of public companies have faced activist investor challenges so far this year.
Merrimack Pharmaceuticals Offers Significant And Uncorrelated Upside Potential
12:00am, Tuesday, 01'st Oct 2019JFL Capital Ends Campaign at Merrimack
08:45pm, Tuesday, 24'th Sep 2019
Pleased Involvement Catalyzed Much Needed Change at Merrimack and Intends to Continue to Monitor Situation LAKEWAY, Texas , Sept. 24, 2019 /PRNewswire/ -- JFL Capital Management, LLC (together with i
Should You Buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) For This Reason?
07:23pm, Thursday, 19'th Sep 2019
As the US$72m market cap Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) released another year of negative earnings...
Merrimack Pharmaceuticals Announces Changes to Board of Directors
01:00pm, Thursday, 19'th Sep 2019
Company Enters into Cooperation Agreement with Newtyn Management and Western Standard
